Opening clinical trial data: Are the voluntary data-sharing portals enough?

Nophar Geifman, Jennifer Bollyky, Sanchita Bhattacharya, Atul J. Butte

Research output: Contribution to journalComment/debate

37 Scopus citations

Abstract

Data generated by the numerous clinical trials conducted annually worldwide have the potential to be extremely beneficial to the scientific and patient communities. This potential is well recognized and efforts are being made to encourage the release of raw patient-level data from these trials to the public. The issue of sharing clinical trial data has recently gained attention, with many agreeing that this type of data should be made available for research in a timely manner. The availability of clinical trial data is most important for study reproducibility, meta-analyses, and improvement of study design. There is much discussion in the community over key data sharing issues, including the risks this practice holds. However, one aspect that remains to be adequately addressed is that of the accessibility, quality, and usability of the data being shared. Herein, experiences with the two current major platforms used to store and disseminate clinical trial data are described, discussing the issues encountered and suggesting possible solutions.

Original languageEnglish
Article number280
JournalBMC Medicine
Volume13
Issue number1
DOIs
StatePublished - 11 Nov 2015
Externally publishedYes

Keywords

  • Clinical data
  • Clinical trials
  • Meta-analysis
  • Open access
  • Reanalysis

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Opening clinical trial data: Are the voluntary data-sharing portals enough?'. Together they form a unique fingerprint.

Cite this